Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis P Garrison

Showing results (121-130 of 190) with videos related to

Pageof 19
Sort By:
Academic Radiology|April 2, 2017
Using the Analytic Hierarchy Process for Prioritizing Imaging Tests in Diagnosis of Suspected AppendicitisMaria Agapova, Brian W Bresnahan, Ken F Linnau, et al.
Academic Radiology|April 5, 2017
Toward a Framework for Benefit-Risk Assessment in Diagnostic Imaging: Identifying Scenario-specific CriteriaMaria Agapova, Brian W Bresnahan, Ken F Linnau, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3]Darius N Lakdawalla, Jalpa A Doshi, Louis P Garrison, et al.
Transplantation and Cellular Therapy|June 26, 2023
Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation PatientRichard T Maziarz, Steven Devine, Louis P Garrison, et al.
Therapeutic Advances in Cardiovascular Disease|December 25, 2015
The potential cost-effectiveness of the Diamondback 360® Coronary Orbital Atherectomy System for treating de novo, severely calcified coronary lesions: an economic modeling approachJeffrey Chambers, Philippe Généreux, Arthur Lee, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 4, 2009
Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part IILouis P Garrison, Edward C Mansley, Thomas A Abbott, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|May 15, 2012
Patients' experience and outcomes after laparoscopic adjustable gastric banding in Washington stateVincent W Lin, Andrew Wright, David R Flum, et al.
The Journal of Infectious Diseases|June 14, 2011
Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccinationLouis P Garrison, Chris T Bauch, Brian W Bresnahan, et al.
Clinical Therapeutics|December 16, 2021
Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health BenefitNihar Desai, Jipan Xie, Yan Wang, et al.
Annals of Surgery|October 7, 2011
The use, safety and cost of bariatric surgery before and after Medicare's national coverage decisionDavid R Flum, Steve Kwon, Kara MacLeod, et al.
Pageof 19

Showing results (121-130 of 190) with videos related to

Sort By:
Pageof 19
Academic Radiology|April 2, 2017
Using the Analytic Hierarchy Process for Prioritizing Imaging Tests in Diagnosis of Suspected AppendicitisMaria Agapova, Brian W Bresnahan, Ken F Linnau, et al.
Academic Radiology|April 5, 2017
Toward a Framework for Benefit-Risk Assessment in Diagnostic Imaging: Identifying Scenario-specific CriteriaMaria Agapova, Brian W Bresnahan, Ken F Linnau, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3]Darius N Lakdawalla, Jalpa A Doshi, Louis P Garrison, et al.
Transplantation and Cellular Therapy|June 26, 2023
Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation PatientRichard T Maziarz, Steven Devine, Louis P Garrison, et al.
Therapeutic Advances in Cardiovascular Disease|December 25, 2015
The potential cost-effectiveness of the Diamondback 360® Coronary Orbital Atherectomy System for treating de novo, severely calcified coronary lesions: an economic modeling approachJeffrey Chambers, Philippe Généreux, Arthur Lee, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 4, 2009
Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part IILouis P Garrison, Edward C Mansley, Thomas A Abbott, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|May 15, 2012
Patients' experience and outcomes after laparoscopic adjustable gastric banding in Washington stateVincent W Lin, Andrew Wright, David R Flum, et al.
The Journal of Infectious Diseases|June 14, 2011
Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccinationLouis P Garrison, Chris T Bauch, Brian W Bresnahan, et al.
Clinical Therapeutics|December 16, 2021
Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health BenefitNihar Desai, Jipan Xie, Yan Wang, et al.
Annals of Surgery|October 7, 2011
The use, safety and cost of bariatric surgery before and after Medicare's national coverage decisionDavid R Flum, Steve Kwon, Kara MacLeod, et al.
Pageof 19